Annual report [Section 13 and 15(d), not S-K Item 405]

Equity Compensation - Schedule of Stock Option Activity (Details)

v3.25.0.1
Equity Compensation - Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Dec. 31, 2022
Stock Options      
Beginning balance outstanding (in shares) 719,525 700,729  
Granted (in shares) 0 18,796  
Exercised (in shares) (2,069)    
Forfeited (in shares) (40,871) 0  
Ending balance outstanding (in shares) 676,585 719,525 700,729
Outstanding, unvested (in shares) 339,340    
Vested not exercised (in shares) 337,245    
Weighted-Average Exercise Price, per share      
Beginning balance outstanding (in dollars per share) $ 9.4 $ 9.4  
Granted (in dollars per share)  
Exercised (in dollars per share)    
Forfeited (in dollars per share)  
Ending balance outstanding (in dollars per share) 9.4 9.4 $ 9.4
Vested and payable (in dollars per share) 9.4 $ 9.4 $ 9.4
Vested not exercised (in dollars per share) $ 9.4    
Weighted average remaining contractual life (in years) 7 years 4 months 24 days 8 years 4 months 24 days 9 years 9 months 18 days
Weighted average remaining contractual life, vested not exercised (in years) 7 years 4 months 24 days    
Aggregate intrinsic value $ 0.0 $ 2.0 $ 0.1
Unvested, intrinsic value $ 0.0